Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmpeak Energy Regulatory News (AMP)

Share Price Information for Ampeak Energy (AMP)

Share Price is delayed by 15 minutes
Get Live Data
2.70    0.00 (0.00%)
Bid:
2.60
Ask:
2.80
Spread: 0.20 (7.692%)
Market Cap: £19.52m
AMP Live PriceLast checked at - London Stock Exchange

Intraday Ampeak Energy Share Chart

Trading Statement

17 Jan 2008 07:01

Amphion Innovations PLC17 January 2008 Amphion Innovations plc Trading Update 17 January 2008 - Amphion Innovations plc (LSE: AMP) ('Amphion' or the'Company'), is pleased to announce that results for the 12 month period to 31December 2007 are expected to show an increase in Net Asset Value per Share of29% to $0.44 (£0.22), broadly in line with market expectations. Profit beforeTax is expected to be approximately $10.5 million, a 50% increase from theprevious year, primarily reflecting the uplift in the value of the investments. Amphion builds shareholder value in high growth companies in the medical andtechnology sectors, by using a focused, hands-on company building approach,based on decades of experience in both the US and UK. Currently there are 10Partner Companies developing proven technologies targeting substantialcommercial marketplaces, in excess of $1 billion. Each Partner Company aims toachieve a target exit value in excess of $100 million supported by Amphionmanagement team's strong track record of delivering liquidity events. During 2007, Amphion successfully helped its Partner Companies raise over $21million. Looking ahead, the Company expects to build on the substantial progress made in2007. Following a successful fundraising, WellGen is in a strong position tomeet its commercial objectives in 2008, having raised $9.5 million in October2007. Durham Scientific Crystals is also well placed following the signing of acontract with the UK Home Office in December 2007. The contract is to developits groundbreaking technology for digital x-ray imaging for use in both medicalapplications and airport security scanners to detect explosives and flammablematerial. Amphion is pleased to report that its Gulf based joint venture, MSA, has beenfully incorporated and capitalized. This will enable it to move forward with thecompany's business plan and to develop strategic partnerships for Amphion andits Partner Companies in the Gulf region. During 2007 Amphion continued to develop its two new Partner Companies, EnergyTrading International ('ETI') and DataTern Inc. ETI seeks to exploit the trendtowards automation of markets through the development of a proprietary(patented) platform for the automatic negotiation and execution of bilateral,structured trades. DataTern Inc. is being formed to develop and extract valuefrom the substantial and growing patented portfolio in Amphion's PartnerCompanies. The Company estimates that its Partner Companies have over 150individual pieces of intellectual property, double the amount at the time oflisting in August 2005. Amphion expects to announce its preliminary results for the 12 months to 31December 2007, in March 2008. Richard C.E. Morgan, Amphion's Chief Executive Officer, said: "During 2007,Amphion and our Partner Companies achieved several key milestones. We arefocused on creating shareholder value, and given the strength of our PartnerCompanies, we are very confident of being able to continue to deliver furthergrowth." For further information please contact: Amphion InnovationsCharlie Morgan:+1 (212) 210-6224 Cardew GroupTim Robertson/ Jamie Milton/Matthew Law:+44 020 7930 0777 Charles Stanley Securities, Nominated AdvisorMark Taylor/ Freddy Crossley:+44 020 7149 6000 On the web: www.amphionplc.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Aug 20187:15 amRNSMotif Bio notes statement from Amphion Innovations
21st Aug 20187:00 amRNSSale of Partner Company Shares
1st Aug 20184:47 pmRNSResult of AGM
29th Jun 20187:00 amRNSDirectorate Change
26th Jun 20187:00 amRNSFinal Results
23rd May 20187:00 amRNSMotif Bio notes statement from Amphion Innovations
23rd May 20187:00 amRNSSale of Partner Company Shares
20th Apr 20187:00 amRNSDirectorate Change
29th Mar 20187:00 amRNSAIM Admission & First Day of Dealings
29th Mar 20187:00 amRNSUpdate on Polarean Imaging IPO
26th Mar 20187:31 amRNSUpdate on Polarean Imaging proposed AIM IPO
2nd Mar 20187:00 amRNSConvertible promissory note extended to December
10th Jan 20185:09 pmRNSDirector dealing
22nd Dec 20177:01 amRNSComment on Polarean Fund Raise
22nd Dec 20177:00 amRNSRestructure of Loan and Additional Drawdown
5th Dec 20177:00 amRNSIssue of Shares
23rd Nov 20177:00 amRNSFurther Update on Polarean Imaging Limited
10th Nov 20177:00 amRNSUpdate on Polarean Imaging Limited
2nd Nov 20177:00 amRNSOrder Dismissing DataTern Case
11th Oct 20177:00 amRNSRelated Party Transaction
5th Oct 20177:00 amRNSPartner Company releases positive clinical results
29th Sep 20177:00 amRNSHalf-year Report
25th Sep 20177:01 amRNSHolding(s) in Company
25th Sep 20177:00 amRNSSale of Partner Company Shares
30th Aug 20177:00 amRNSSale of partner company shares
30th Aug 20177:00 amRNSHolding(s) in Company
1st Aug 20175:19 pmRNSAGM Statement
28th Jun 20177:00 amRNSFinal Results
31st May 20177:00 amRNSPartner Company m2m Imaging merger update
22nd May 20174:36 pmRNSAdditional Draw Down on Loan Facility
7th Feb 20177:00 amRNSAdditional Draw Down on Loan Facility
1st Feb 20175:18 pmRNSHolding(s) in Company
30th Dec 20162:38 pmRNSHolding(s) in Company
16th Dec 20163:07 pmRNSDirector/PDMR Shareholding
9th Dec 20163:50 pmRNSDirector/PDMR Shareholding
24th Nov 20162:15 pmRNSHolding(s) in Company
8th Sep 20167:00 amRNSRe-negotiated terms of Motif CPN
7th Sep 20167:00 amRNSInterim Results for the six months to 30 June 2016
22nd Aug 20163:58 pmRNSAdditional Draw Down on Loan Facility
3rd Aug 20164:13 pmRNSHolding(s) in Company
29th Jul 20167:00 amRNSResults of AGM and Directorate Change
18th Jul 20164:33 pmRNSTransfer of Shares
13th Jul 20167:01 amRNSNotice of Intention to List on NASDAQ by Motif Bio
13th Jul 20167:00 amRNSAdditional Draw Down on Loan Facility
23rd Jun 20167:00 amRNSFinal Results
29th Apr 20164:02 pmRNSAdditional Terms on Loan Facility
28th Apr 20167:00 amRNSAdditional Draw Down on Loan Facility
7th Apr 20167:00 amRNSAmphion settles contested arbitration ruling
3rd Mar 20167:00 amRNSConvertible Promissory Note Extended
7th Jan 20167:00 amRNSDirectors' Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.